Will regulators say yes?
That’s the big question for the $66 billion Bayer \–Monsanto acquisition deal. If approved, it would be the ninth largest merger ever.
Both companies gained about $1 (U.S.) on the U.S. and European Stock Exchanges in earlier trading this week.
Bayer sells both farm and healthcare products, while Monsanto sells genetically modified seeds and other ag products.
Bayer has said it will pay a $2 billion "break fee" to Monsanto if the deal doesn’t go through.
To learn more, watch the segment of AgDay that accompanies this article.